×

menu
Penana
US
search
search
Popular Tags
What Others Are Reading
Loginarrow_drop_down
Registerarrow_drop_down
Please use Chrome or Firefox for better user experience!
close
Comments close
Show more...


favorite
0
comment
0
arrow_back_ios_new
Prev
arrow_back_ios_new
Next
format_color_text
Style
open_in_full
Expand
list
Menu
coins
Sponsor
campaign
Request update
share
Share
report
Report
×
Login first to show your name as a sponsor, or donate with Pena Coins.

× Pena Coins Credit Card

Close
People Who Like This
#3

Drug Related Problems

薏米 薏米
May 22, 2025 72 1 Min Read
No Plagiarism!pHqYclgmxgm8NSW1V6kwposted on PＥNAＮＡ

In 1990, Helper and Strand published a paper named "Opportunities and Responsibilities in Pharmaceutical Care" in which drug-related problems (DRPs) were classified into 8 categories:

1.  Untreated indications

2.  Improper drug selection

3.  Sub-therapeutic dosage

4.  Failure to receive drugs (non-compliance)

5.  Overdosage

6.  Adverse drug reactions

7.  Drug interactions

8.  Drug use without indication

216.73.216.250

ns216.73.216.250da2
favorite
comment 0
coins
0 likes
Be the first to like this issue!
Next Issue >
close
阿波羅
home
Bookmark!
campaign Request update 0
Table of Contents
keyboard_arrow_down No Volume 1 chapter
#0 Intro
keyboard_arrow_down 序章 3 chapters
#1 引子
#2 案件目錄
#3 Drug Related Problems
keyboard_arrow_down Marathon（馬拉松） 12 chapters
#4 Marathon（馬拉松）人物簡介
#5 Chapter 1 （馬拉松 - 1）
#6 Chapter 2 （馬拉松 - 2）
#7 Chapter 3 （馬拉松 - 3）
#8 Chapter 4 （馬拉松 - 4）
#9 Chapter 5 （馬拉松 - 5）
#10 Chapter 6 （馬拉松 - 6）
#11 Chapter 7（馬拉松 - 7）
#12 Chapter 8 （馬拉松 - 8）
#13 Chapter 9 （馬拉松 - 9）
#14 Chapter 10 （馬拉松 - 10）
#15 Chapter 11 （馬拉松 - 11）
keyboard_arrow_down Fandom（粉絲圈） 12 chapters
#16 Fandom（粉絲圈）人物簡介
#17 Chapter 12 （粉絲圈 - 1）
#18 Chapter 13（粉絲圈 - 2）
#19 Chapter 14（粉絲圈 - 3）
#20 Chapter 15（粉絲圈 - 4）
#21 Chapter 16（粉絲圈 - 5）
#22 Chapter 17 （粉絲圈 - 6)
#23 Chapter 18（粉絲圈 - 7）
#24 Chapter 19（粉絲圈 - 8)
#25 Chapter 20（粉絲圈 - 9）
#26 Chapter 21（粉絲圈 - 10）
#27 Chapter 22（粉絲圈 - 11）
keyboard_arrow_down The Fourth Estate（第四權） 16 chapters
#28 The Fourth Estate（第四權）人物簡介
#29 Chapter 23（第四權 - 1）
#30 Chapter 24（第四權 - 2）
#31 Chapter 25（第四權 - 3）
#32 Chapter 26（第四權 - 4）
#33 Chapter 27（第四權 - 5）
#34 Chapter 28（第四權 - 6）
#35 Chapter 29（第四權 - 7）
#36 Chapter 30（第四權 - 8）
#37 Chapter 31（第四權 - 9）
#38 Chapter 32（第四權 - 10）
#39 Chapter 33（第四權 - 11）
#40 Chapter 34（第四權 - 12）
#41 Chapter 35（第四權 - 13）
#42 Chapter 36（第四權 - 14）
#43 Chapter 37（第四權 - 15）
keyboard_arrow_down Foxglove（毛地黃） 11 chapters
#44 Foxglove（毛地黃）人物簡介
#45 Chapter 38（毛地黃 - 1）
#46 Chapter 39（毛地黃 - 2）
#47 Chapter 40（毛地黃 - 3）
#48 Chapter 41（毛地黃-4）
#49 Chapter 42（毛地黃 - 5）
#50 Chapter 43（毛地黃 - 6）
#51 Chapter 44（毛地黃 - 7）
#52 Chapter 45（毛地黃 - 8）
#53 Chapter 46（毛地黃 - 9）
#54 Chapter 47（毛地黃 - 10）
keyboard_arrow_down Promised Land（白衣人） 2 chapters
#55 公告
#56 Promised Land（白衣人）人物簡介
× Share Email
Click to Share!
Share to Facebook
Share to Twitter
 content_copy
Copy link to clipboard
 share
Other options
Share this Publication by Email
Add a personal message
×

Proceed

×
format_size
remove_circle_outline 20 add_circle_outline
format_line_spacing remove_circle_outline 20 add_circle_outline
REGISTER
LOGIN

Forget Password?
OR
Login with Facebook
×
Subscribe
Go to the magazine
/
+ Add tip
The tip will be charged every payment period
+ Add promotion code
Apply close
Recipient Name

Shipping address



Phone Number


JOIN
Pay with
xxxx xxxx xxxx
Update payment method
Confirm Cancel
This is a one-time purchase.
If you don't cancel before the trial ends, you will automatically be charged the subscription fee every until you cancel. Renews automatically every , unless you decide to cancel. You can cancel your subscription at any time.
You can pay with non-card methods if you subscribe for 12 months.
Please leave your contact phone number here..
We will reach you soon by Whatsapp at the tel number you provide.
Please enter phone number.

Credit card payment

You have subscribed to this plan already!

Never miss what's happening on Penana!
Turn on notifications
Later
Close
×
Interface Language:
Story Language: